Glucose transporters, which transfer glucose from the blood to the brain, are inhibited by E. coli K1 during bacterial meningitis, leaving insufficient fuel for immune cells to fight off infection, report researchers. Their findings may lead to a novel way of treating children with meningitis and reducing long-term neurological problems.